Dr Wu, the person whose clinical trial (CRISPR/PD-1/Tcell) in China ended in a disaster, wants to speak out – but no-one wants to hear.

 Dec 28, WSJ: “Dr. Wu said he attempted to publish his research, but that some Western academic journals declined to accept it. He didn’t elaborate.”

July 2019, pulitzercenter.org: “All but one of Wu’s patients have died, and, as often happen with negative data, he told me that he has had difficulty publishing a paper that describes his failed esophageal cancer treatment”

And he ““had a second reason for not wanting to pursue another CRISPR-modified intervention that struck me as far more profound than concerns about overly strict oversight. Wu cautions that the technology doesn’t make wonder drugs. “I don’t know why CRISPR has such a fantastic influence on people,”

In fact, they published intermediate data in an American Journal in Jul 2018, saying 10/21 patients had died.

Amazingly, that paper has 0 citations in a year and half (Nov 2019).

Similarly, biorxiv scuttles any attempt that shows the dangers of creating transgenic humans (Cas9 integration) – three such rejections for me. Here is one in F1000.